Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at First Recurrence: A Preliminary Report

Yun Guan,Jing Li,Xiu Gong,Huaguang Zhu,Chao Li,Guanghai Mei,Xiaoxia Liu,Li Pan,Jiazhong Dai,Yang Wang,Enmin Wang,Xin Wang,Ying Liu

Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at First Recurrence: A Preliminary Report

2021

Yun Guan
Jing Li
Xiu Gong
Huaguang Zhu
Chao Li
Guanghai Mei
Xiaoxia Liu
Li Pan
Jiazhong Dai
Yang Wang
Enmin Wang
Xin Wang
Ying Liu

e14015Background: The optimal treatment for recurrent glioblastoma (rGBM) remains uncertain. Hypofractionated stereotactic radiotherapy (HSRT) and anti-vascular endothelial growth factor (VEGF) ant...

Keywords:

Targeted therapy
Oncology
preliminary report
stereotactic radiotherapy
Glioblastoma
Internal medicine
Text mining
First Recurrence
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations